In clinical practice, breast cancer is classified into different subtypes based on the expression of hormone receptors (HRs), including estrogen receptor (ER) and progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (Waks and Winer, 2019). Here, PGR is linked to breast cancer.